1 Tex. Admin. Code § 354.1891 - Vendor Drug Providers Subject to Audit
(a) All providers participating in the Vendor
Drug Program (Program) are subject to periodic audits by the Texas Health and
Human Services Commission (the Commission) or contractors for the Centers for
Medicare & Medicaid Services.
(b) Audits determine provider compliance with
all state and federal program policies, procedures, and limitations as well as
compliance with the requirements outlined in the provider's contract. Data for
transactions selected for audit are compared with data on the corresponding
prescriptions. Erroneous payments and overpayments that occur because of
noncompliance with Program requirements are considered exceptions subject to
restitution to the Commission.
(c)
If a provider disagrees with the initial findings of an audit, the provider may
present additional documentation to the auditor for review within 15 calendar
days of the provider's receipt of the draft audit report. No additional
documentation is accepted after this time. The auditor considers the additional
documentation before issuing the Final Audit Report.
(d) If the provider disagrees with the Final
Audit Report and wants to appeal, and the findings of the audit do not include
findings that the pharmacy engaged in Medicaid fraud, the Commission's Appeals
Division, upon receipt of written request, provides an informal hearing. The
Commission's Appeals Division must receive the written request for an informal
hearing within 15 calendar days of the provider's receipt of the Final Audit
Report.
(e) An administrative law
judge (ALJ) from the Commission's Appeals Division conducts hearings requested
under subsection (d) of this section in an informal manner. Unless specified by
the ALJ and at the ALJ's sole discretion, neither the Texas Rules of Civil
Procedure nor the Texas Rules of Evidence or any other procedural or
evidentiary rules apply. The ALJ only considers data or documentation provided
to the auditors on or before the time specified in subsection (c) of this
section. The ALJ makes the final decision. Vendor Drug Program staff who have
expertise in the law governing pharmacies' participation in Medicaid are
available to the ALJ to answer questions.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.